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Abstract  15 
Molecular typing at the 18S rRNA and Gp60 loci was conducted on Cryptosporidium- 16 
positive stool samples from cases collected during 2007 Western Australian and South  17 
Australian outbreaks of cryptosporidiosis. Analysis of 48 Western Australian samples  18 
identified that all isolates were C. hominis and were from five different Gp60 C. hominis  19 
subtype families. The IbA10G2 subtype was most common across all age groups (37/48). In  20 
South Australia, analysis of 24 outbreak samples, identified 21 C. hominis isolates, two C.  21 
parvum isolates and one sample with both C. hominis and C. parvum. All C. hominis isolates  22 
were identified as the IbA10G2 subtype.  23 
  24 
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1. Introduction  27 
  28 
Cryptosporidium species are parasites that infect a wide range of hosts including  29 
humans, domestic and wild animals. In most cases, including those in humans,  30 
Cryptosporidium infection results in gastrointestinal problems such as severe diarrhoea.  31 
Currently 21 species of Cryptosporidium are recognised as valid and at least eight of them  32 
have been reported in humans; C. hominis, C. parvum, C. meleagridis, C. felis, C. canis, C.  33 
muris, and C. suis, and the Cryptosporidium cervine genotype. Of these, C. hominis and C.  34 
parvum are responsible for the majority of infections in humans (Xiao and Fayer, 2008; Xiao,  35 
2009).  36 
To understand the transmission dynamics of Cryptosporidium, various  37 
fingerprinting/subtyping tools have been developed, one of the most popular of which is  38 
sequence analysis of the 60 kDa glycoprotein (Gp60, also called gp15/40). It is the most  39 
polymorphic marker identified so far in the Cryptosporidium genome (Gatei et al., 2006;  40 
Leoni et al., 2007; Wielinga et al., 2008). It is also biologically relevant as it encodes surface  41 
glycoproteins (gp45 and gp15), both of which are implicated in zoite attachment to and  42 
invasion of enterocytes (Strong et al., 2000).  43 
In Australia, Cryptosporidium is a notifiable disease and evidence to date suggests that  44 
C. hominis is the predominant species infecting humans but that there is a higher prevalence  45 
of C. parvum in the human population in New South Wales (NSW) and South Australia (SA)  46 
than in Western Australia (WA) (Robertson et al., 2002; Chalmers et al., 2005; Jex et al.,  47 
2007; Ng et al., 2008; O’Brien et al., 2008; Morgan et al., 2008; Jex, et al., 2008; Alagappan  48 
et al., 2008; Waldron et al., 2009a; 2009b).   49 
From January to May 2007, there was a large increase in the number of notified  50 
cryptosporidiosis cases in WA, with 476 cases reported. This was three times the mean  51 
notification rate from the previous four years (Gibbs et al., 2008). Cases ranged in age from 4  52 ACCEPTED MANUSCRIPT 
4 
months to 89 years (median 8 years), with 43% of cases in the <5 year age group. No gender  53 
disparity was observed, with 49% of cases male and 51% female. The majority of cases  54 
(67%) resided in the Perth metropolitan area. Non-Aboriginal people represented 69% of  55 
notified cases, with 13% of cases from Aboriginal people, predominantly from the north of  56 
WA. Indigenous status was unknown for 18% of cases. The total number of cases reported for  57 
2007 was 625, which was a rate of 30 cases per 100,000 population (Gibbs et al., 2008). The  58 
demography of cases from this outbreak year was similar to cases from non-outbreak years  59 
(2004, 2005 and 2006) with the exception of geography and indigenous status. In the outbreak  60 
year the proportion of cases from the metropolitan area was higher, and the proportion of  61 
indigenous cases was lower.   62 
Similarly in SA in 2007, there was a large increase in the number of notified cases of  63 
cryptosporidiosis between January and the end of April with 393 cases reported (Anon, 2007).  64 
Cases ranged in age from <1 month to 87 years (median 10 years), with 32% of cases within  65 
the 0-4 year age group. No gender disparity was observed, with 45% of cases male and 55%  66 
female. The majority of cases (78%) resided in the Adelaide metropolitan area. Non- 67 
Aboriginal people represented 82% of notified cases, with 1% of cases from Aboriginal  68 
people. Indigenous status was unknown for 17% of cases. The total number of cases reported  69 
for 2007 was 449 cases, which was over twice the notification for the preceding year and  70 
seven times the number of cases for the subsequent year (Anon, 2007).  71 
The aim of the present study was to identify the Cryptosporidium species present in  72 
the WA and SA outbreaks and to subtype the isolates at the Gp60 locus to determine the  73 
subtypes present.  74 
  75 ACCEPTED MANUSCRIPT 
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2. Materials and methods  76 
  77 
2.1 Specimens and DNA extraction  78 
  79 
A total of 72 faecal samples associated with the Cryptosporidium  outbreaks were  80 
received from various pathology centers, of which 48 were from Western Australia and 25  81 
were from South Australia. Total DNA was extracted immediately upon receipt, using a  82 
QIAmp DNA Stool Kit (Qiagen, Hilden, Germany) and stored at -20°C.   83 
  84 
2.2 PCR Amplification and DNA sequencing  85 
  86 
Initial genotyping of the samples were carried out by a two-step nested PCR of the  87 
18S rRNA locus (Ryan et al., 2003). The secondary PCR products were purified using a  88 
Power Soil DNA Kit (MolBio, Carlsbad, California, USA) according to manufacturer’s  89 
protocol and sequenced using an ABI Prism Dye Terminator Kit (Applied Biosystems, Foster  90 
City, California).  91 
Isolates were sub-genotyped at the Gp60 gene locus using a two-step nested PCR  92 
which amplifies a secondary PCR fragment of ~832bp as previously described (Strong et al,  93 
2000). Purification and sequencing of the amplified DNA fragments were carried out as  94 
described above.  95 
Nucleotide sequences were analyzed using Chromas lite version 2.0  96 
(http://www.technelysium.com.au) and aligned using Clustal W (http://clustalw.genome.jp).   97 
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3. Results  99 
  100 
3.1 Western Australia  101 
  102 
All of 48 isolates from WA were identified as C. hominis at the 18S locus (Table I).  103 
At the Gp60 locus, five different C. hominis Gp60 subtype families were identified; Ib, Id, Ie,  104 
If and Ig (Table I). Within the C. hominis Ib family, IbA10G2 was the only subtype identified  105 
and was the most common subtype identified in the WA cases genotyped (37/48). The second  106 
most common Gp60 subtype family was the C. hominis Id family (6/48). Three subtypes were  107 
identified within the C. hominis Id family; IdA16 (3/6), IdA15G1 (2/6) and IdA17 (1/6). The  108 
other subtypes identified included C. hominis IeA11G3T3 (1/48), C. hominis IfA12G1 (1/48)  109 
and C. hominis IgA17 (3/48).   110 
Although not systematically sampled, the samples genotyped were representative of  111 
the overall outbreak in terms of age and gender distribution (Table II). A lower proportion of  112 
samples from rural cases were typed compared to the overall outbreak, which may have  113 
decreased the probability of identifying C. parvum. The majority of the samples typed (94%)  114 
were collected during the outbreak period again demonstrating that the typing results were,  115 
for the most part, representative of the overall outbreak.  116 
 As genotyping was conducted towards the end of the epidemiological investigation,  117 
only a quarter of those cases that had isolates genotyped were interviewed. Therefore it was  118 
not possible to examine subtype specific risk factors. However, 171 interviews were  119 
conducted out of the 476 notified cases. All interviewed cases, resided in the metropolitan  120 
area. The case series identified that in the two weeks prior to onset of symptoms, 64% of  121 
cases swam in a pool, 53% had contact with pets, 22% were children that attended day care  122 
centres, 16% reported contact with a person with a diarrhoeal illness, 14% had contact with  123 ACCEPTED MANUSCRIPT 
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farm animals and 10% drank water from a private (untreated) water supply (Gibbs et al.  124 
2008). Eleven of the interviewed cases were hospitalized as a result of their illness.  125 
The age range for these 48 WA isolates genotyped was <1 to 76 (Table I).  The  126 
highest prevalence was amongst children <5 years of age (39.6%) but was also common  127 
amongst older age groups with the second highest peak, amongst the 16-39 age group (Table  128 
I). The IbA10G2 subtype was identified across all age groups.   129 
  130 
3.2 South Australia  131 
  132 
Of the 24 isolates from SA, 21 were C. hominis, 2 were C. parvum and 1 isolate was a  133 
mixed C. hominis/C. parvum infection (Table I). At the Gp60 locus, all 21 of the C. hominis  134 
isolates belonged to the C. hominis IbA10G2 subtype. The two C. parvum isolates belonged  135 
to the C. parvum IIaA18G3R1 subtype. Isolate SA17, which was a mixed C. parvum/C.  136 
hominis infection exhibited the C. hominis IbA10G2 and the C. parvum IIaA19G3R1  137 
subtypes respectively.  138 
The age range for the 24 SA isolates was <1 to 74 (Table II). The highest prevalence  139 
occurred in the 16-29 age-group (37.5%), followed by the <5 age group (29.2%). As with the  140 
WA outbreak, the IbA10G2 subtype was distributed across all age-groups (Table I). Of the 24  141 
isolates examined, 30% were from regional locations in SA and the remainder (n = 15) were  142 
from metropolitan Adelaide. Of the 8 isolates from rural locations, only one was identified as  143 
C. parvum.   144 
Limited epidemiological investigations were conducted in SA. Initial phone interviews  145 
with 30 individuals identified that 20 people had used public swimming pools, 3 had used  146 
private swimming pools, 1 drank rainwater, 1 swam in the Murray River, 1 swam in a farm  147 
dam, 1 had fallen into a septic tank and 3 had family members with gastrointestinal illness  148 
consistent with cryptosporidiosis, but did not submit faecal specimens for testing.   149 ACCEPTED MANUSCRIPT 
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3.3 Gp60 nucleotide sequence accession numbers  150 
  151 
Representative Gp60 subtypes identified during the present study have been deposited  152 
in the GenBank database under accession numbers GU810905-GU810914.  153 
  154 
4. Discussion  155 
  156 
In the present study, the anthroponotic C. hominis was the most prevalent  157 
Cryptosporidium species identified in both cryptosporidiosis outbreaks in WA and SA. In  158 
WA, all isolates genotyped (48) were C. hominis, whereas in SA, C. hominis was identified in  159 
87.5% (21/24) of isolates, C. parvum was identified in 8.3% of samples (2/24) and a mixed C.  160 
hominis/C. parvum infection was identified in one patient.   161 
There was a broad spread of age groups infected during both the WA and SA  162 
outbreaks. In WA, 32% of cases were in children less than 5 years of age, with a second peak  163 
(27%) in the 16-39 age group. In SA, the highest infection rate was amongst the 16-39 age  164 
group (37.5%), followed by the <5 age group (29.2%). Cryptosporidial infections are  165 
predominately reported in children <5 years of age (Fayer, 2007), but the present results  166 
reveal a higher peak of infection in the 16-39 age group in SA and highlight the fact that all  167 
age-groups are susceptible to infection with Cryptosporidium. The peak in the 16-39 age  168 
group, may be due to adults and teenagers caring for infected children becoming infected  169 
themselves.  170 
A case series conducted in WA identified that 64% of interviewed cases swam in a  171 
pool prior to onset of illness. Twenty-three SA cases reported swimming in a pool prior to  172 
onset of illness. While these data indicate that swimming pools could be a source of infection,  173 
it is important to note that neither state conducted a case-control study. Therefore, the  174 ACCEPTED MANUSCRIPT 
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proportion of non-infected people that swam in that time frame was unknown, and it could not  175 
be determined whether swimming was a significant risk factor Cryptosporidium infection.   176 
Waterborne transmission of Cryptosporidium through swimming in contaminated  177 
pools is now recognized as an important transmission route for Cryptosporidium and  178 
approximately 50.3% (83) of the reported outbreaks of cryptosporidiosis worldwide have  179 
been due to contamination of swimming pools (Karanis et al., 2007). Contamination in  180 
swimming pools is often associated with accidental faecal contamination and poorly  181 
constructed and/or maintained plumbing (Joce et al., 1991). It is possible that outbreaks begin  182 
in swimming pools but then become transmitted from human to human through contact with  183 
children, fomites etc. To date, no studies have been conducted in Australia on  184 
Cryptosporidium contamination levels and genotypes in public swimming pools. This work is  185 
urgently needed to better understand the transmission dynamics in the human population in  186 
Australia.  187 
In the present study, all the WA isolates genotyped were C. hominis, whereas in the  188 
SA isolates, C. parvum was detected in 3 isolates. This supports previous research reporting a  189 
higher prevalence of C. parvum in the human population in NSW, Victoria and SA than in  190 
WA (Robertson, et al., 2002; Chalmers et al, 2005; Jex et al., 2007; Ng et al., 2008; O’Brien  191 
et al., 2008; Jex, et al., 2008; Alagappan et al., 2008; Waldron et al., 2009a; 2009b). For  192 
example, in NSW, a recent study of 69 sporadic cases of cryptosporidiosis identified C.  193 
hominis in ~53% (37/69) and C. parvum in ~46% (32/69) (Waldron et al., 2009a). Why this  194 
appears to be the case is difficult to determine. In the present study, an analysis of the SA  195 
outbreak samples indicated that only one of the C. parvum isolates identified from SA was  196 
from a rural location.   197 
Determining the prevalence of C. hominis and C. parvum in human populations is  198 
important as recent reports strongly suggest that there are different clinical manifestations  199 
between  C. parvum and C. hominis, particularly in children. In a study of sporadic  200 ACCEPTED MANUSCRIPT 
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cryptosporidiosis in the UK, illness was more severe in persons infected with C. hominis than  201 
in those infected with C. parvum (Hunter et al., 2004a; 2004b). In addition, C. hominis but not  202 
C. parvum was associated with an increased risk of non-intestinal symptoms such as joint  203 
pain eye pain, headaches, dizzy spells and fatigue (Hunter et al., 2004b). In a study of  204 
children infected with Cryptosporidium in Brazil, C. hominis infections were associated with  205 
higher oocyst shedding in stools as well as with greater shortfalls in growth in the post- 206 
infection period even in the absence of symptoms (Bushen et al., 2007). A 4-year longitudinal  207 
birth cohort of 533 children in Peru, reported that C. hominis was associated with diarrhea,  208 
nausea, vomiting, general malaise, and increased oocyst shedding intensity and duration. In  209 
contrast, C. parvum, C. meleagridis, C. canis, and C. felis were associated with diarrhea only  210 
(Cama et al., 2008).  211 
Gp60 subtyping indicated that the C. hominis IbA10G2 subtype was the most  212 
prevalent subtype identified in both the WA and SA outbreaks. The C. hominis Ib subtype  213 
family is the most frequently detected Cryptosporidium spp. in waterborne outbreaks of  214 
cryptosporidiosis in industrialized nations (Xiao, 2009). The C. hominis IbA10G2 subtype  215 
has been common in sporadic human cryptosporidiosis cases in the UK, US, Peru, Slovenia  216 
and South Africa (Peng et al., 2001; Leav et al., 2002; Zhou et al., 2003; Chalmers et al.,  217 
2005; Alves et al., 2006; Soba and Logar, 2008). The IbA10G2 subtype is also common in  218 
NSW (Ng et al., 2008; Waldron et al., 2009b), and is the subtype responsible for the 2009  219 
NSW outbreak (Waldron et al., 2009c). Previous studies in WA and SA have reported a  220 
prevalence of ~20-50% of the IbA10G2 subtype amongst sporadic C. hominis infections (Jex  221 
et al., 2008; O’Brien et al., 2008).  Few studies have examined the association between  222 
specific Gp60 subtype families and clinical symptoms. A recent study has reported that while  223 
all  C.  hominis subtype families were associated with diarrhoea, only C.  hominis subtype  224 
family Ib was also associated with nausea, vomiting, and general malaise (Cama et al., 2008).   225 
The C. hominis subtypes Id, Ig, Ie and If were also detected in the WA outbreak  226 ACCEPTED MANUSCRIPT 
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isolates.  Id subtypes are common in industralised countries and the Ig subtype has previously  227 
been reported in a drinking-water associated outbreak in Northern Ireland (Glaberman et al.,  228 
2002). Subtype If is less common. All the Id, Ig, and If subtypes identified in the present  229 
study, have been previously reported in WA human isolates (O’Brien et al., 2008). Subtype  230 
IeA11G3T3 found in a single isolate from WA, is a cause of sporadic cryptosporidiosis  231 
around the world (Xiao, 2009). Amongst the SA C. parvum isolates, subtype IIaA18G3R1was  232 
identified in 2/3 C. parvum positive human isolates. This subtype has been identified as the  233 
most common subtype in cattle in Perth, WA (O'Brien et al., 2008), Tamworth, NSW (Ng et  234 
al., 2008), Canada (Trotz-Williams et al., 2006) and Northern Ireland (Thompson et al.,  235 
2007).  236 
In conclusion, the C. hominis IbA10G2 was the pre-dominant subtype identified in  237 
both the WA and SA outbreak samples. No conclusive link between the outbreak and a source  238 
of contamination was determined.  239 
  240 
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  371 
Table I. Distribution of Cryptosporidium species and subtypes in different age groups in WA  372 
and SA outbreaks, for samples that were genotyped.  373 
  374 
State Age  range 
(yrs) 
No of 
cases 
% Species Gp60 subtype  No. of 
subtypes 
<5  23  47.9  Ib A10G2  
Id A16  
Id A17 
1g A17   
18 
1 
1 
3 
5-15  6  12.5  1b A10G2  
1d A16  
5 
1 
16-39  13  27.1  1b A10G2  
1d A16  
1d A15G1  
10 
1 
2 
WA 
40-90 6  12.5 
C. hominis 
1b A10G2  
1e A11G3T3 
IfA21G1 
4 
1 
1 
Total    48        48 
<5 7  29.2  C. hominis  Ib A10G2  7 
5-15 3  12.5  C. hominis  Ib A10G2  3 
16-39 9  37.5  C. hominis   
+ C. parvum 
Ib A10G2 
IIa A18G3R1 
8 
1 
40-90 4  16.7  C. hominis  
+ C. parvum 
1b A10G2 
IIa A19G4R1* 
3 
1 
SA 
UK 1  4.1  C. parvum  IIa A18G3R1  1 
Total   24       24 
UK =  age unknown  375 
*mixed C. parvum IIa A19G4R1 and C. hominis Ib A10G2 infection.  376 
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  378 
Table II. Comparison of demographic information for samples that were genotyped and  379 
overall outbreak data for WA and SA.  380 
  381 
  382 
  Demographic 
Information 
Overall outbreak  Samples typed 
Age range  0-89 years  0-76 years 
Median age  8 years  6.5 years 
< 5 years old (%)  43  46 
Male (%)  49  42 
Female (%)  51  58 
Urban (%)  67  79 
Rural (%)  33  19 
WA 
Date of specimen 
collection 
1/1/2007  
31/5/2007 
13/3/2007  
15/8/2007 
SA  Age range  0-87 years  0-74 years 
  Median age  10 years  25 years 
  <5 years old (%)  32  29 
 Male  (%)  45  35 
 Female  (%)  55  65 
 Urban  (%)  78  70 
 Rural  (%)  22  30 
 Date  of  specimen 
collection 
N/A N/A 
NA = not available.  383 
  384 
  385 